Loading...

Equillium, Inc.

EQ•NASDAQ
Healthcare
Biotechnology
$1.98
$-0.07(-3.41%)
U.S. Market opens in 1h 45m

Equillium, Inc. (EQ) Stock Overview

Explore Equillium, Inc.’s financial performance, market position, analyst ratings, and future outlook.

Meyka AI Score

Z

Key Financials

Market Cap70.3M
P/E Ratio-8.31
EPS (TTM)$-0.39
ROE-1.19%
Fundamental Analysis

AI Price Forecasts

1 Month$1.81
3 Months$1.16
1 Year Target$1.36

EQ Stock Analysis & Investment Overview

Our comprehensive AI-powered analysis of Equillium, Inc. (EQ) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B+, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.

The current technical analysis reveals key indicators including an RSI of 52.58, suggesting the stock is in a neutral condition. Our forecasting models predict significant price movements, with a 12-month target of $1.36.

Key financial metrics showcase the company's fundamental strength, including a P/E ratio of -8.31 and a market capitalization of 70.3M. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.

1-Day Change
-3.41%
5-Day Change
3.13%
1-Month Change
-14.66%
3-Month Change
72.17%
6-Month Change
60.98%
Year-to-Date (YTD) Change
27.74%
1-Year Change
352.67%
3-Year Change
171.23%
5-Year Change
-70.18%
All-Time (Max) Change
-85.86%

Contact Information

https://equilliumbio.com
858 412 5302
2223 Avenida De La Playa, La Jolla, CA, 92037

Company Facts

35 Employees
IPO DateOct 12, 2018
CountryUS
Actively Trading

Frequently Asked Questions